03 srinivasan covid 508

CDC ACIP — Vaccine Advisory Committee

Acip

Slides

13

Document text

COVID-19 Vaccination Implementation National Center for Immunization and Respiratory Di seases 
September 19, 2025 Immunization Services Division Centers for Disease Control and Prevention 
•National Immunization Survey (NIS): 
-Random-digit-dial cellular telephone survey of adul ts age ≥18 years in the U.S. (all 
50 states, 5 local jurisdictions, and territories);  all responses are self reported. 
-Sample size: ~15,000 adult respondents weekly, ~60, 000 adult respondents monthly 
-Data are weighted to represent the non-institutiona lized U.S. population Data sources used to estimate U.S. immunization coverage 
COVID-19 Vaccination Coverage 
National Immunization Survey-Fall Respiratory Virus Module 
0.0 20.0 40.0 60.0 80.0 
9/7/2024 
9/14/2024 9/21/2024 9/28/2024 10/5/2024 
10/12/2024 10/19/2024 10/26/2024 
11/2/2024 11/9/2024 
11/16/2024 11/23/2024 11/30/2024 
12/7/2024 
12/14/2024 12/21/2024 12/28/2024 
1/4/2025 
1/11/2025 1/18/2025 1/25/2025 
2/1/2025 2/8/2025 
2/15/2025 2/22/2025 
3/1/2025 3/8/2025 
3/15/2025 3/22/2025 3/29/2025 
4/5/2025 
4/12/2025 4/19/2025 4/26/2025 
Vaccination coverage (%) 
Week ending date ≥65 years 
50-64 years 
18-49 years COVID-19 Vaccination Coverage (≥1 Dose) Among Adults 1 8-49 Years, 50-64 
Years, and 65 Years and Older, 2024-2025 
National Immunization Survey National Immunization Survey National Immunization Survey National Immunization Survey- - --Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module 
44.1 24.6 
14.1 
025 50 75 100 
Sep 7 
Sep 14 Sep 21 Sep 28 
Oct 5 
Oct 12 Oct 19 Oct 26 
Nov 2 Nov 9 
Nov 16 Nov 23 Nov 30 
Dec 7 
Dec 14 Dec 21 Dec 28 
Jan 4 
Jan 11 Jan 18 Jan 25 
Feb 1 Feb 8 
Feb 15 Feb 22 
Mar 1 Mar 8 
Mar 15 Mar 22 Mar 29 
Apr 5 
Apr 12 Apr 19 Apr 26 
Sep 7 
Sep 14 Sep 21 Sep 28 
Oct 5 
Oct 12 Oct 19 Oct 26 
Nov 2 Nov 9 
Nov 16 Nov 23 Nov 30 
Dec 7 
Dec 14 Dec 21 Dec 28 
Jan 4 
Jan 11 Jan 18 Jan 25 
Feb 1 Feb 8 
Feb 15 Feb 22 
Mar 1 Mar 8 
Mar 15 Mar 22 Mar 29 
Apr 5 
Apr 12 Apr 19 Apr 26 
Sep 7 
Sep 14 Sep 21 Sep 28 
Oct 5 
Oct 12 Oct 19 Oct 26 
Nov 2 Nov 9 
Nov 16 Nov 23 Nov 30 
Dec 7 
Dec 14 Dec 21 Dec 28 
Jan 4 
Jan 11 Jan 18 Jan 25 
Feb 1 Feb 8 
Feb 15 Feb 22 
Mar 1 Mar 8 
Mar 15 Mar 22 Mar 29 
Apr 5 
Apr 12 Apr 19 Apr 26 
Sep 7 
Sep 14 Sep 21 Sep 28 
Oct 5 
Oct 12 Oct 19 Oct 26 
Nov 2 Nov 9 
Nov 16 Nov 23 Nov 30 
Dec 7 
Dec 14 Dec 21 Dec 28 
Jan 4 
Jan 11 Jan 18 Jan 25 
Feb 1 Feb 8 
Feb 15 Feb 22 
Mar 1 Mar 8 
Mar 15 Mar 22 Mar 29 
Apr 5
Apr 12Apr 19Apr 26
18-49 years 50-64 years 65-74 years ≥75 years Vaccination coverage (%) 
2024-25 season week ending date Vaccination coverage (2024-25) Vaccination coverage (2023-24) COVID-19 Vaccination Coverage (≥1 Dose) Among Adults  ≥18 Years, 65-
74 Years, and ≥75 Years, 2023-24 and 2024-25 
National Immunization Survey-Fall Respiratory Virus  Module 
24.6 24.1 42.7 37.9 46.5
38.3
14.1 14.1 
025 50 75 100 Vaccination coverage (%) 
Week ending date Overall (6 months-17 years) 6 months-4 years 5-11 years 12-17 years COVID-19 Vaccination Coverage* Among Children 6 Mont hs–17 Years of 
Age, October 2024–April 2025, NIS-Flu 
* Up-to-date with the updated 2024–25 COVID-19 vacc ine is defined as receipt of at least one vaccinati on since August 22, 2024, for children ≥5 years; fo r children <5 years, up-to-
date status was defined based on the current recomm endations that also take into account number of dose s and brand of vaccine. Up-to-date status was deter mined by survey 
questions on month and year of most recent COVID-19  vaccine, and for children <5 years, total number o f COVID-19 vaccinations received and brand of most recent COVID-19 
vaccine. /uni2009
2.4 16.6 10.5 0.8 1.4 9.9 8.1 
0.0 10.0 20.0 30.0 40.0 50.0 60.0 18-49 (n=85) 50-64 (n=98) 18-64 (n=183) 65+ (n=172) Male (n=95) Female (n=257) Overall 18+ immunocompromised (n=355) 
Weighted % (95% CI) COVID-19 Vaccination Coverage (≥2 Doses) Among Adults 18 Years and Older 
Who Are Immunocompromised Who Received First Dose in August/September 
2024, as of End of March 2025 
National Immunization Survey National Immunization Survey National Immunization Survey National Immunization Survey- - --Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module 
*Immunocompromised a dults were recommended to receive a second dose of 2 024-2025 COVID-19 vaccine 
six months after their first dose .
•COVID-19 vaccination coverage for older adults impro ved in 2024-2025 
compared to the previous season, but vaccination cover age for adults 18-
64 years was similar between the 2023-2024 and 2024-20 25 seasons. 
•Approximately 13% of children between 6 months and 1 7 years of age 
were up to date with COVID vaccination at the end o f April 2025. Summary 
Place of COVID-19 Vaccination Among Adults 18 Years an d Older, 2024-2025 
National Immunization Survey National Immunization Survey National Immunization Survey National Immunization Survey- - --Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module Fall Respiratory Virus Module 
*Among persons who reported receiving a 2024-2025 CO VID-19 vaccination since August 22, 2024 (n=9,359).  Data collected April 1-27, 2025. 67.3 
12.5 8.5 5.9 1.7 1.5 1.3 0.7 0.6 0.2 
020 40 60 80 100 Weighted % (95% CI) Reported place of 2024-2025 COVID-19 vaccination, a dults age ≥18 years*, United States 
COVID-19 Vaccination Coverage among Health Care Personnel 
National Healthcare Safety Network 
•CDC’s National Healthcare Safety Network (NHSN) is the most widely used 
healthcare associated infection tracking system and  provides important 
quality measures like healthcare personnel (HCP) va ccination status 
•CMS-certified healthcare facilities are required to  report monthly COVID-
19 vaccination data and annual influenza vaccinatio n data for HCP 
•Across all healthcare facility types, the largest g roups of submitters are 
Acute Care Hospitals and Nursing Homes Estimating vaccination coverage through NHSN 
COVID-19 and influenza vaccine coverage among healthcare personnel (HCP) 2022-2025* 
17 15 
10 23 
11 
881 81 
78 
47 45 
42 
010 20 30 40 50 60 70 80 90 
2 0 2 2 - 2 0 2 3 2 0 2 3 - 2 0 2 4 2 0 2 4 - 2 0 2 5 Vaccination Coverage (%) 
COVID-19 vaccine coverage: Acute care hospital HCP COVID-19 vaccine coverage: Long term care HCP 
Influenza vaccine coverage: Acute care hospital HCP Influenza vaccine coverage: Long term care HCP 
References: 1. Influenza and Up-to-Date COVID-19 Vaccination Co verage Among Health Care Personnel — National Healthc are Safety Network, United States, 2022–23 Influenz a Season | MMWR 
2. Influenza and COVID-19 Vaccination Coverage Among  Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus S eason | MMWR 
*2024-2025 Data were collected from acute care hosp itals and nursing homes on HCP influenza and up-to-d ate COVID-19 vaccination coverage for the week ending  March 30, 2025. NHSN defined up-to-date COVID-19 vac cination during that 
time as the receipt of ≥1 dose of a 2024–2025 COVID -19 vaccination. 
For more information, contact CDC/ATSDR 1-800-CDC-INFO (232-4636) TTY:  1-888-232-6348    www.cdc.gov           www.a tsdr.cdc.gov 
The findings and conclusions in this report are tho se of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention a nd the Agency for Toxic Substances and Disease Regi stry. 
Thank you